Patent: 6,217,866

✉ Email this page to a colleague

Summary for Patent: 6,217,866

Scope and claims summary:

Title:	Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
Abstract:	Hybridoma cell lines producing monoclonal antibodies specific to the human epidermal growth factor receptor are disclosed. The antibodies are capable of inhibiting the growth of human tumor cells expressing human epidermal growth factor receptors. Therapeutic uses of these monoclonal antibodies by themselves and in combination with anti-neoplastic agents are also disclosed.
Inventor(s):	Schlessinger; Joseph (New York, NY), Givol; David (Rehovot, IL), Bellot; Francoise (Fresnes, FR), Kris; Richard (Tucson, AZ), Ricca; George A. (Blue Bell, PA), Cheadle; Christopher (West Chester, PA), South; Victoria J. (Audubon, PA)
Assignee:	Rhone-Poulenc Rorer International (Holdings), Inc. (Greenville, DE)
Application Number:	08/487,761
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,217,866
Patent Claims:	see list of patent claims

Details for Patent 6,217,866

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	February 12, 2004	⤷ Subscribe	2018-04-17
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	March 28, 2007	⤷ Subscribe	2018-04-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,217,866

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
Netherlands	300353	⤷ Subscribe
Netherlands	300351	⤷ Subscribe
Netherlands	300350	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.